Miles Lachlan F, Pac Soo Vanessa, Braat Sabine, Burgess Adele, Heritier Stephane, Smart Philip, Tan Nicole, Parker Anna, Burbury Kate L, Story David A
Department of Critical Care, Melbourne Medical School, The University of Melbourne, Melbourne, Australia.
Department of Anaesthesia, Austin Health, Melbourne, Australia.
Colorectal Dis. 2023 Feb;25(2):315-325. doi: 10.1111/codi.16371. Epub 2022 Oct 29.
Preoperative absolute and functional iron deficiency anaemia is associated with poor postoperative outcomes in patients undergoing surgery for colorectal cancer. It is biologically plausible that "early", or "nonanaemic" iron deficiency may also be associated with worse postoperative outcomes in similar cohorts, albeit at lesser severity than that seen for anaemia. The evidence supporting this assertion is of low quality.
We have designed a prospective, observational study to delineate associations between preoperative non-anaemic iron deficiency and postoperative outcomes after surgery for colorectal cancer. Patients without anaemia, undergoing elective surgery for colorectal cancer will be allocated to an iron replete or an iron deficient group based on preoperative transferrin saturation. The primary outcome is days alive and at home on postoperative day 90. Secondary outcomes include days alive and at home on postoperative day 30, length of hospital stay, readmission to acute care, postoperative complications, health-related quality of life scores, quality of postoperative recovery, and requirement for allogeneic blood transfusion. The planned sample size is 422 patients, which has 80% power to detect a two-day difference in the primary outcome. The study commenced in May 2019.
The results of this study will provide patients and clinicians with high-quality evidence concerning associations between nonanaemic iron deficiency and patient-centred outcomes after surgery for colorectal cancer. The study will be conducted in multiple urban and rural centres across Australia and New Zealand. The results will be highly generalisable to contemporary surgical practice and should be rapidly translated.
术前绝对缺铁性贫血和功能性缺铁性贫血与接受结直肠癌手术患者的术后不良结局相关。“早期”或“非贫血性”缺铁也可能与类似队列中较差的术后结局相关,尽管严重程度低于贫血患者,从生物学角度来看这是合理的。支持这一论断的证据质量较低。
我们设计了一项前瞻性观察性研究,以明确术前非贫血性缺铁与结直肠癌手术后的术后结局之间的关联。将接受择期结直肠癌手术且无贫血的患者根据术前转铁蛋白饱和度分为铁充足组或缺铁组。主要结局指标。主要结局是术后第90天存活且在家的天数。次要结局包括术后第30天存活且在家的天数、住院时间、再次入住急症护理、术后并发症、健康相关生活质量评分、术后恢复质量以及异体输血需求。计划样本量为422例患者,有80%的把握度检测出主要结局指标有两天的差异。该研究于2019年5月开始。
本研究结果将为患者和临床医生提供高质量证据,证明非贫血性缺铁与结直肠癌手术后以患者为中心的结局之间的关联。该研究将在澳大利亚和新西兰的多个城乡中心进行。研究结果将高度适用于当代外科实践,并且应能迅速转化应用。